Free Daily Podcast Summary
The BioHub - by Avetix: Daily Summaries Delivered
by Max Brennan - Biotech HeadHunter
Welcome to The BioHub, where the doors to the world of biotechnology swing wide open. Join your host, Max Brennan, a seasoned biotech recruiter, as he engages in thought-provoking conversations with the brightest minds in biotech. This podcast is your backstage pass to the insights, strategies, and stories that fuel success in the dynamic and ever-evolving biotech landscape. Get ready for an immersive experience into the world of biotech with The BioHub.
Latest Episodes
The most recent episodes — sign up to get AI-powered summaries of each one.
- 6 days ago26 min
Episode 206 - Valerie Vanhooren - CEO & Co-Founder Ona Therapeutics
In this episode of The BioHub by Avetix, I'm joined by Valerie Vanhooren, CEO and Co-Founder of Ona Therapeutics.Recorded shortly after Ona Therapeutics announced its $85 million Series B, Valerie shares the journey behind building the company, the challenges of fundraising in today's biotech market, and the opportunity to develop next-generation precision oncology therapies that improve outcomes for patients with cancer.We also discuss the evolution of antibody-drug conjugates (ADCs), what it takes to build a biotech from the ground up, the importance of company culture, and Valerie's vision for the future of precision oncology.
- 1 weeks ago22 min
Episode 205 - Paul Bresge - CEO of Ray Therapeutics
Paul didn't stumble into biotech, he was pulled in by a diagnosis. When a doctor told his daughter to prepare for a life without her sight due to retinitis pigmentosa, he went all in on finding the best science out there to give patients like her new hope. Today he leads Ray Therapeutics, who're developing optogenetic gene therapies designed to restore vision, not just slow its loss, for patients who are already out of other options. We talk about the science, the personal mission, and what's coming next.
- 1 weeks ago29 min
Episode 204 - Samir Ounzain - Co-founder & CEO Haya Therapeutics
In this episode of The BioHub by Avetix, I'm joined by Samir Ounzain, CEO and Co-Founder of HAYA Therapeutics.Samir shares the journey from pioneering research into the so-called "dark genome" to building one of biotech's most exciting RNA therapeutics companies. We discuss why long non-coding RNAs could unlock an entirely new class of precision medicines, the challenge of turning groundbreaking science into a business, and how HAYA is approaching diseases with significant unmet need.We also explore the importance of resilience in biotech, the evolution from scientist to CEO, the role AI is beginning to play in drug discovery, and what the future holds for RNA therapeutics and precision medicine.
- 1 weeks ago26 min
Episode 203 - Tim Noyes - CEO of Newleos Therapeutics
In this episode of The BioHub Podcast, Ben is joined by Tim Noyes, President and CEO of Newleos Therapeutics.Tim reflects on more than 35 years across the life sciences industry, from beginning his career at Merck to building and leading emerging biotechnology companies. He shares why he has consistently been drawn to smaller organisations, where leadership teams can remain close to the science, the patients and the people driving the company forward.The conversation explores Newleos’ mission to rethink the treatment of anxiety and other neuropsychiatric conditions through a pipeline of differentiated GABA-A receptor modulators originally licensed from Roche. Tim discusses the opportunity to retain the therapeutic benefits associated with GABA modulation while overcoming the limitations of traditional benzodiazepines, including the company’s clinical programmes in generalised anxiety disorder and social anxiety disorder.They also discuss the importance of patient access, the challenges of reimbursement in the US healthcare system, and why humility, appreciation and a people-focused culture are central to Tim’s approach to leadership.
- 1 weeks ago33 min
Episode 202 - Ben Swanson - CEO of Skeletalis
Today we're joined by Ben Swanson, Founder and CEO of Skeletalis, a biotechnology company developing a new generation of precision medicines for bone disease.Ben's path into biotech is anything but conventional. Trained as both a dentist and a scientist, he founded Skeletalis to tackle one of the biggest unmet challenges in musculoskeletal health: how to deliver treatments directly to the parts of the skeleton that need them most, while minimizing effects on the rest of the body.At Skeletalis, Ben and his team have developed the OASIS platform—a targeted drug delivery approach designed to direct therapies to sites of active bone remodeling. Their lead focus is osteoporosis, a disease affecting hundreds of millions of people worldwide, with the potential to transform how bone diseases are treated in the future.In this conversation, we'll explore Ben's journey from academia to entrepreneurship, what it takes to build a biotech company from groundbreaking research, the future of precision medicine, and why solving bone health could have a profound impact on healthy aging
- 2 weeks ago23 min
Episode 201 - Bennett Smith - SVP Commercial Beren Therapeutics
In this episode of The BioHub Podcast, Max sits down with Bennett Smith, Senior Vice President of Commercial at Beren Therapeutics.Bennett has spent more than two decades building commercial organisations and bringing innovative medicines to patients, holding leadership roles at Novo Nordisk, Regeneron, Akebia, and Orchard Therapeutics, where he helped launch one of the world's most expensive gene therapies.Today, he's leading commercial strategy at Beren Therapeutics, a clinical-stage biotech taking a different approach to developing treatments for rare diseases.In this conversation, we discuss Bennett's journey through biotech, why commercial thinking should begin long before launch, the story behind Beren's emergence from stealth, and what it takes to build a successful commercial organisation from the ground up.We also explore the future of rare disease innovation and why aligning science and commercial strategy from day one can make all the difference.
- 2 weeks ago30 min
Episode 200 - Tassos Gianakakos & Liz Nguyen - Kardigan
What's the right team to build a precision cardiovascular biopharma company?In this episode Tassos Gianakakos CEO and Chief People Officer Liz Nguyen discuss how Kardigan is thinking about talent, culture, and the capabilities required to bring precision medicine to cardiovascular disease.
- 2 weeks ago28 min
Episode 199 - Miles Gerson - Partner at SV Health Investors and Co-Lead of The Dementia Discovery Fund
In this episode of The BioHub Podcast, Ben sits down with Miles Gerson, Partner at SV Health Investors and Co-Lead of the Dementia Discovery Fund.Miles shares his perspective on investing in neuroscience, building companies around emerging biology and identifying approaches with the potential to change the treatment landscape in dementia and neurodegenerative disease.The conversation explores how the Dementia Discovery Fund assesses scientific risk, what makes a neuroscience company investable, where the strongest opportunities are emerging, and how investors can help translate promising research into viable therapeutic companies.Miles also discusses the evolution of dementia drug development, the role of company creation and what the next generation of successful neuroscience businesses will need to get right.
About The BioHub - by Avetix
Welcome to The BioHub, where the doors to the world of biotechnology swing wide open. Join your host, Max Brennan, a seasoned biotech recruiter, as he engages in thought-provoking conversations with the brightest minds in biotech. This podcast is your backstage pass to the insights, strategies, and stories that fuel success in the dynamic and ever-evolving biotech landscape. Get ready for an immersive experience into the world of biotech with The BioHub.
Customized Recaps
AI-powered recaps with compact key takeaways, quotes, and insights.
Straight to Your Inbox
Get key takeaways from The BioHub - by Avetix in a 5-minute read.
Save Hours Every Week
Stay current on your favorite podcasts without falling behind.
Frequently Asked Questions
What is Podzilla's The BioHub - by Avetix daily summary?
It's a free AI-powered email that summarizes new episodes of The BioHub - by Avetix as soon as they're published. You get the key takeaways, notable quotes, and links & mentions — all in a quick read.
How does the The BioHub - by Avetix podcast summary work?
When a new episode drops, our AI transcribes and analyzes it, then generates a personalized summary tailored to your interests and profession. It's delivered to your inbox every morning.
Is this an official The BioHub - by Avetix product?
No. Podzilla is an independent service that summarizes publicly available podcast content. We're not affiliated with or endorsed by Max Brennan - Biotech HeadHunter.
Can I get summaries of other podcasts too?
Absolutely! The free plan covers up to 3 podcasts. Upgrade to Pro for 15, or Premium for 50. Browse our full catalog at /podcasts.
How often does The BioHub - by Avetix release new episodes?
The BioHub - by Avetix publishes every few days. Our AI generates a summary within hours of each new episode.
What topics does The BioHub - by Avetix cover?
The BioHub - by Avetix covers topics including Science, Life Sciences. Our AI identifies the specific themes in each episode and highlights what matters most to you.
Start getting The BioHub - by Avetix summaries tomorrow morning.
Free forever for up to 3 podcasts. No credit card required.
Free forever for up to 3 podcasts. No credit card required.